litlas
Log inCreate account

Peter S. Hammerman

Active 2003–2021

80
Papers
40,055
Citations
74
h-index
80
i10-index

Citations

Citations per year for Peter S. Hammerman1976: 2 citations1980: 1 citations1995: 1 citations1998: 1 citations1999: 1 citations2000: 1 citations2003: 3 citations2004: 35 citations2005: 52 citations2006: 60 citations2007: 66 citations2008: 62 citations2009: 73 citations2010: 71 citations2011: 77 citations2012: 108 citations2013: 342 citations2014: 503 citations2015: 767 citations2016: 893 citations2017: 931 citations2018: 953 citations2019: 2,255 citations2020: 2,570 citations2021: 2,293 citations2022: 1,687 citations2023: 1,140 citations2024: 1,497 citations2025: 696 citations2026: 30 citations1977–1979: no citations, so these years are not shown1981–1994: no citations, so these years are not shown1996–1997: no citations, so these years are not shown2001–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,448 citing papers, 28.6% of this breakdownChina: 3,759 citing papers, 16.7% of this breakdownUnited Kingdom: 1,160 citing papers, 5.2% of this breakdownGermany: 1,033 citing papers, 4.6% of this breakdownItaly: 897 citing papers, 4% of this breakdownJapan: 865 citing papers, 3.8% of this breakdownFrance: 718 citing papers, 3.2% of this breakdownCanada: 678 citing papers, 3% of this breakdownSpain: 634 citing papers, 2.8% of this breakdownSouth Korea: 502 citing papers, 2.2% of this breakdownAustralia: 462 citing papers, 2.1% of this breakdownNetherlands: 430 citing papers, 1.9% of this breakdown
0%28.6%Other 21.9%

Institutions

Fields

  • Medicine48.9%
  • Biochemistry, Genetics and Molecular Biology41%
  • Immunology and Microbiology6.5%
  • Computer Science0.9%
  • Engineering0.4%
  • Chemistry0.4%
  • Other1.9%

Topics

  • Cancer Immunotherapy and Biomarkers7.1%
  • Cancer Genomics and Diagnostics5.6%
  • Lung Cancer Treatments and Mutations5.5%
  • RNA modifications and cancer2.8%
  • Immunotherapy and Immune Responses2.7%
  • Epigenetics and DNA Methylation2.6%
  • Other73.7%

Coauthors

All papers

Open in search
  1. Comprehensive molecular profiling of lung adenocarcinoma

    Authors: Eric A. Collisson, Barry S. Taylor, Joshua D. Campbell, Angela N. Brooks, Alice H. Berger, Juliann Chmielecki, Gad Getz, Peter S. Hammerman, Bryan Hernandez, Carrie Sougnez, Andrew D. Cherniack, Mara Rosenberg, Matthew Meyerson, Stacey B. Gabriel, Kristian Cibulskis, Jaegil Kim, Chip Stewart, Lee Lichtenstein, Eric S. Lander, Michael S. Lawrence, Marcin Imielinski, Robert C. Onofrio, Travis Zack, Elena Helman, Chandra Sekhar Pedamallu, Jill Mesirov, Gordon Saksena, Steven E. Schumacher, Scott L. Carter, Levi Garraway, Rameen Beroukhim, Juok Cho, Daniel DiCara, David Heiman, Pei Lin, William Mallard, Douglas Voet, Hailei Zhang, Lihua Zou, Michael S. Noble, Nils Gehlenborg, Helga Thorvaldsdottir, Marc-Danie Nazaire, Jim Robinson, William Lee, Marc Ladanyi, Nikolaus Schultz, Ronglai Shen, William D. Travis, B. Arman Aksoy, Giovanni Ciriello, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, Venkatraman E. Seshan, Boris Reva, Rileen Sinha, S. Onur Sumer, Nils Weinhold, Chris Sander, Natasha Rekhtman, Maureen Zakowski, Valerie W. Rusch, David G. Beer, Leslie Cope, Ludmila Danilova, James G. Herman, Stephen B. Baylin, Peter Illei, Edward Gabrielson, James Shin, Beverly Lee, Kristen Rodgers, Dante Trusty, Malcolm V. Brock, Chad J. Creighton, David Wheeler, Li Ding, Ramaswamy Govindan, Cyriac Kandoth, Robert Fulton, Lucinda L. Fulton, Michael D. McLellan, Richard K. Wilson, Kai Ye, Catrina C. Fronick, Christopher A. Maher, Christopher A. Miller, Michael C. Wendl, Christopher Cabanski, Elaine Mardis, Mark A. Watson, Sandra McDonald, Bryan Meyers, Raju Kucherlapati, Angela Hadjipanayis, Eran Hodis, Semin Lee, Angeliki Pantazi, Xiaojia Ren and 210 more - Nature 2014 cited by 5,918

  2. Mutational heterogeneity in cancer and the search for new cancer-associated genes

    Authors: Michael S. Lawrence, Petar Stojanov, Paz Polak, Gregory V. Kryukov, Kristian Cibulskis, Andrey Sivachenko, Scott L. Carter, Chip Stewart, Craig H. Mermel, Steven A. Roberts, Adam Kieżun, Peter S. Hammerman, Aaron McKenna, Yotam Drier, Lihua Zou, Alex H. Ramos, Trevor J. Pugh, Nicolas Stransky, Elena Helman, Jaegil Kim, Carrie Sougnez, Lauren Ambrogio, Elizabeth Nickerson, Erica Shefler, Maria L. Cortés, Daniel Auclair, Gordon Saksena, Douglas Voet, Michael S. Noble, Daniel DiCara, Pei Lin, Lee Lichtenstein, David I. Heiman, Timothy R. Fennell, Marcin Imieliński, Bryan Hernandez, Eran Hodis, Sylvan C. Baca, Austin Dulak, Jens G. Lohr, Dan-Avi Landau, Catherine J. Wu, Jorge Meléndez-Zajgla, Alfredo Hidalgo‐Miranda, Amnon Koren, Steven A. McCarroll, Jaume Mora, Ryan S. Lee, Brian D. Crompton, Robert C. Onofrio, Melissa Parkin, Wendy Winckler, Kristin Ardlie, Stacey Gabriel, Charles W.M. Roberts, Jaclyn A. Biegel, Kimberly Stegmaier, Adam J. Bass, Levi A. Garraway, Matthew Meyerson, Todd R. Golub, Dmitry A. Gordenin, Shamil Sunyaev, Eric S. Lander, Gad Getz - Nature 2013 cited by 5,755

  3. Comprehensive genomic characterization of squamous cell lung cancers

    Authors: Peter S. Hammerman, Michael S. Lawrence, Douglas Voet, Rui Jing, Kristian Cibulskis, Andrey Sivachenko, Petar Stojanov, Aaron McKenna, Eric S. Lander, Gad Getz, Marcin Imielinski, Elena Helman, Bryan Hernandez, Nam H. Pho, Matthew Meyerson, Gordon Saksena, Andrew D. Cherniack, Stephen E. Schumacher, Barbara Tabak, Scott L. Carter, Huy Nguyen, Andrew Crenshaw, Rameen Beroukhim, Wendy Winckler, Hailei Zhang, Sachet Shukla, Lynda Chin, Michael Noble, Doug Voet, Nils Gehlenborg, Daniel DiCara, Spring Yingchun Liu, Lihua Zou, Pei Lin, Juok Cho, Marc-Danie Nazaire, Jim Robinson, Helga Thorvaldsdottir, Jill Mesirov, Chang-Jiun Wu, Bruce Johnson, David Kwiatkowski, Bruce E. Johnson, Carrie Sougnez, Stacey Gabriel, Robert C. Onofrio, Kristin Ardlie, Andy Chu, Hye-Jung E. Chun, Andrew J. Mungall, Erin Pleasance, A. Gordon Robertson, Payal Sipahimalani, Dominik Stoll, Miruna Balasundaram, Inanc Birol, Yaron S. N. Butterfield, Eric Chuah, Robin J. N. Coope, Richard Corbett, Noreen Dhalla, Ranabir Guin, An He, Carrie Hirst, Martin Hirst, Robert A. Holt, Darlene Lee, Haiyan I. Li, Michael Mayo, Richard A. Moore, Karen Mungall, Ka Ming Nip, Jacqueline E. Schein, Jared R. Slobodan, Angela Tam, Nina Thiessen, Richard Varhol, Thomas Zeng, Yongjun Zhao, Steven J. M. Jones, Marco A. Marra, Elizabeth Chun, Andy Mungall, Gordon Robertson, Adam Olshen, Alexei Protopopov, Jianhua Zhang, Xiaojia Ren, Jinhua Zhang, Jianjua John Zhang, Angela Hadjipanayis, Peng-Chieh Chen, Raju Kucherlapati, Psalm Haseley, Eunjung Lee, Peter J. Park, Semin Lee, Ruibin Xi, Lixing Yang, Nicholas D. Socci and 239 more - Nature 2012 cited by 4,052

  4. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

    Authors: Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Grit S. Herter-Sprie, Kevin A. Buczkowski, William G. Richards, Leena Gandhi, Amanda J. Redig, Scott J. Rodig, Hajime Asahina, Robert E. Jones, Meghana Kulkarni, Mari Kuraguchi, Sangeetha Palakurthi, Peter E. Fecci, Bruce E. Johnson, Pasi A. Jänne, Jeffrey A. Engelman, Sidharta P. Gangadharan, Daniel B. Costa, Gordon J. Freeman, Raphael Bueno, F. Stephen Hodi, Glenn Dranoff, Kwok‐Kin Wong, Peter S. Hammerman - Nature Communications 2016 cited by 1,570

  5. Non-small-cell lung cancers: a heterogeneous set of diseases

    Authors: Zhao Chen, Christine M. Fillmore, Peter S. Hammerman, Carla F. Kim, Kwok‐Kin Wong - Nature reviews. Cancer 2014 cited by 2,023

  6. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

    Authors: Joshua D. Campbell, Anton Alexandrov, Jaegil Kim, Jeremiah A. Wala, Alice H. Berger, Chandra Sekhar Pedamallu, Sachet A. Shukla, Guangwu Guo, Angela N. Brooks, Bradley A. Murray, Marcin Imieliński, Xin Hu, Shiyun Ling, Rehan Akbani, Mara Rosenberg, Carrie Cibulskis, Aruna Ramachandran, Eric A Collisson, David J. Kwiatkowski, Michael S. Lawrence, John N. Weinstein, Roel G.W. Verhaak, Catherine J. Wu, Peter S. Hammerman, Andrew D. Cherniack, Gad Getz, Maxim N. Artyomov, Robert D. Schreiber, Ramaswamy Govindan, Matthew Meyerson - Nature Genetics 2016 cited by 1,234

  7. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

    Authors: Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Amir Reza Aref, Ferdinandos Skoulidis, Grit S. Herter-Sprie, Kevin A. Buczkowski, Yan Liu, Mark M. Awad, Warren L. Denning, Lixia Diao, Jing Wang, Edwin R. Parra-Cuentas, Ignacio I. Wistuba, Margaret Soucheray, Tran C. Thai, Hajime Asahina, Shunsuke Kitajima, Abigail Altabef, Jillian D. Cavanaugh, Kevin Rhee, Peng Gao, Haikuo Zhang, Peter E. Fecci, Takeshi Shimamura, Matthew D. Hellmann, John V. Heymach, F. Stephen Hodi, Gordon J. Freeman, David A. Barbie, Glenn Dranoff, Peter S. Hammerman, Kwok‐Kin Wong - Cancer Research 2016 cited by 630

  8. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

    Authors: Marcin Imieliński, Alice H. Berger, Peter S. Hammerman, Bryan Hernandez, Trevor J. Pugh, Eran Hodis, Jeonghee Cho, James Suh, Marzia Capelletti, Andrey Sivachenko, Carrie Sougnez, Daniel Auclair, Michael S. Lawrence, Petar Stojanov, Kristian Cibulskis, Kyusam Choi, Luc de Waal, Tanaz Sharifnia, Angela N. Brooks, Heidi Greulich, Shantanu Banerji, Thomas Zander, Danila Seidel, Frauke Leenders, Sascha Ansén, Corinna Ludwig, Walburga Engel-Riedel, Erich Stoelben, Jürgen Wolf, Chandra Goparju, Kristin Thompson, Wendy Winckler, David J. Kwiatkowski, Bruce E. Johnson, Pasi A. Jänne, Vincent A. Miller, William Pao, William D. Travis, Harvey I. Pass, Stacey Gabriel, Eric S. Lander, Roman K. Thomas, Levi A. Garraway, Gad Getz, Matthew Meyerson - Cell 2012 cited by 1,840

  9. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

    Authors: Esra A. Akbay, Shohei Koyama, Julián Carretero, Abigail Altabef, Jeremy H. Tchaicha, Camilla L. Christensen, Oliver R. Mikse, Andrew D. Cherniack, Ellen M. Beauchamp, Trevor J. Pugh, Matthew D. Wilkerson, Peter E. Fecci, Mohit Butaney, Jacob B. Reibel, Margaret Soucheray, Travis J. Cohoon, Pasi A. Jänne, Matthew Meyerson, D. Neil Hayes, Geoffrey I. Shapiro, Takeshi Shimamura, Lynette M. Sholl, Scott J. Rodig, Gordon J. Freeman, Peter S. Hammerman, Glenn Dranoff, Kwok‐Kin Wong - Cancer Discovery 2013 cited by 1,242

  10. MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

    Authors: Mark M. Awad, Geoffrey R. Oxnard, David M. Jackman, Daniel O. Savukoski, Dimity Hall, Priyanka Shivdasani, Jennifer Heng, Suzanne E. Dahlberg, Pasi A. Jänne, Suman Verma, James G. Christensen, Peter S. Hammerman, Lynette M. Sholl - Journal of Clinical Oncology 2016 cited by 688

  11. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    Authors: Diana Miao, Claire A. Margolis, Natalie I. Vokes, David Liu, Amaro Taylor‐Weiner, Stephanie A. Wankowicz, Dennis O. Adeegbe, Daniel Keliher, Bastian Schilling, Adam Tracy, Michael P. Manos, Nicole G. Chau, Glenn J. Hanna, Paz Polak, Scott J. Rodig, Sabina Signoretti, Lynette M. Sholl, Jeffrey A. Engelman, Gad Getz, Pasi A. Jänne, Robert I. Haddad, Toni K. Choueiri, David A. Barbie, Rizwan Haq, Mark M. Awad, Dirk Schadendorf, F. Stephen Hodi, Joaquim Bellmunt, Kwok‐Kin Wong, Peter S. Hammerman, Eliezer M. Van Allen - Nature Genetics 2018 cited by 696

  12. LKB1 loss links serine metabolism to DNA methylation and tumorigenesis

    Authors: Filippos Kottakis, Brandon Nicolay, Ahlima Roumane, Rahul Karnik, Hongcang Gu, Julia M. Nagle, Myriam Boukhali, Michele C. Hayward, Yvonne Y. Li, Ting Chen, Marc Liesa, Peter S. Hammerman, Kwok‐Kin Wong, D. Neil Hayes, Orian S. Shirihai, Nicholas J. Dyson, Wilhelm Haas, Alexander Meissner, Nabeel Bardeesy - Nature 2016 cited by 359

  13. In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma

    Authors: Fei Li, Qingyuan Huang, Troy A. Luster, Hai Hu, Hua Zhang, Wai‐Lung Ng, Alireza Khodadadi‐Jamayran, Wei Wang, Ting Chen, Jiehui Deng, Michela Ranieri, Zhaoyuan Fang, Val Pyon, Catríona M. Dowling, Ece Bagdatlioglu, Christina Almonte, Kristen Labbe, Heather Silver, Alexandra R. Rabin, Kandarp Jani, Aristotelis Tsirigos, Thales Papagiannakopoulos, Peter S. Hammerman, Vamsidhar Velcheti, Gordon J. Freeman, Jun Qi, George Miller, Kwok‐Kin Wong - Cancer Discovery 2019 cited by 208

  14. Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

    Authors: Chen Liu, Hengyu Lu, Hongyun Wang, Alice Loo, Xiamei Zhang, Guizhi Yang, Colleen Kowal, Scott Delach, Ye Wang, Silvia Goldoni, William D. Hastings, Karrie Wong, Hui Gao, Matthew J. Meyer, Susan E. Moody, Matthew J. LaMarche, Jeffrey A. Engelman, Juliet Williams, Peter S. Hammerman, Tinya J. Abrams, Morvarid Mohseni, Giordano Caponigro, Huai‐Xiang Hao - Clinical Cancer Research 2020 cited by 165

  15. Fuel feeds function: energy metabolism and the T-cell response

    Authors: Casey Fox, Peter S. Hammerman, Craig B. Thompson - Nature reviews. Immunology 2005 cited by 854

  16. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma

    Authors: Suzanne George, Diana Miao, George D. Demetri, Dennis O. Adeegbe, Scott J. Rodig, Sachet A. Shukla, Mikel Lipschitz, Ali Amin‐Mansour, Chandrajit P. Raut, Scott L. Carter, Peter S. Hammerman, Gordon J. Freeman, Catherine J. Wu, Patrick A. Ott, Kwok‐Kin Wong, Eliezer M. Van Allen - Immunity 2017 cited by 485

  17. Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

    Authors: Tanguy Y. Seiwert, Zhixiang Zuo, Michaela K. Keck, Arun Khattri, Chandra Sekhar Pedamallu, Thomas Stricker, Christopher D. Brown, Trevor J. Pugh, Petar Stojanov, Juok Cho, Michael S. Lawrence, Gad Getz, Johannes Brägelmann, Rebecca DeBoer, Ralph R. Weichselbaum, Alexander Langerman, Louis Portugal, Elizabeth A. Blair, Kerstin Stenson, Mark W. Lingen, Ezra E.W. Cohen, Everett E. Vokes, Kevin P. White, Peter S. Hammerman - Clinical Cancer Research 2014 cited by 658

  18. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

    Authors: Li Zhang, Kenzie D. MacIsaac, Ting Zhou, Pei‐Yu Huang, Chunlin Xin, Jason R. Dobson, Kun Yu, Derek Y. Chiang, Yue Fan, Marc R. Pelletier, Yan Wang, Savina Jaeger, Viveksagar Krishnamurthy Radhakrishnan, Lellean JeBailey, Peter Skewes-Cox, Jing Zhang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Yuanyuan Zhao, En Li, Bin Peng, Alan Huang, Glenn Dranoff, Peter S. Hammerman, Jeffrey A. Engelman, Hans Bitter, Yi‐Xin Zeng, Yao Yao - Molecular Cancer Research 2017 cited by 218

  19. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer

    Authors: Jiehui Deng, Aatish Thennavan, Igor Dolgalev, Ting Chen, Jie Li, Antonio Marzio, John T. Poirier, David H. Peng, Mirna Bulatović, Subhadip Mukhopadhyay, Heather Silver, Eleni Papadopoulos, Val Pyon, Cassandra Thakurdin, Han Han, Fei Li, Shuai Li, Hailin Ding, Hai Hu, Yuanwang Pan, Vajira Weeresekara, Baishan Jiang, Eric S. Wang, Ian M. Ahearn, Mark R. Philips, Thales Papagiannakopoulos, Aristotelis Tsirigos, Eli Rothenberg, Justin F. Gainor, Gordon J. Freeman, Charles M. Rudin, Nathanael S. Gray, Peter S. Hammerman, Michele Pagano, John V. Heymach, Charles M. Perou, Nabeel Bardeesy, Kwok‐Kin Wong - Nature Cancer 2021 cited by 140

  20. Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade

    Authors: Esra A. Akbay, Shohei Koyama, Yan Liu, Ruben Dries, Lauren E. Bufe, Michael Silkes, Md Maksudul Alam, Dillon M. Magee, Robert E. Jones, Masahisa Jinushi, Meghana Kulkarni, Julián Carretero, Xiaoen Wang, Tiquella Warner-Hatten, Jillian D. Cavanaugh, Akio Osa, Atsushi Kumanogoh, Gordon J. Freeman, Mark M. Awad, David C. Christiani, Raphael Bueno, Peter S. Hammerman, Glenn Dranoff, Kwok‐Kin Wong - Journal of Thoracic Oncology 2017 cited by 196

  21. CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer

    Authors: Hua Zhang, Camilla L. Christensen, Ruben Dries, Matthew G. Oser, Jiehui Deng, Brian Diskin, Fei Li, Yuanwang Pan, Xuzhu Zhang, Yandong Yin, Eleni Papadopoulos, Val Pyon, Cassandra Thakurdin, Nicholas Kwiatkowski, Kandarp Jani, Alexandra R. Rabin, Dayanne M. Castro, Ting Chen, Heather Silver, Qingyuan Huang, Mirna Bulatović, Catríona M. Dowling, Belen Sundberg, Alan L. Leggett, Michela Ranieri, Han Han, Shuai Li, Annan Yang, Kristen Labbe, Christina Almonte, Vladislav O. Sviderskiy, Max M. Quinn, Jack F. Donaghue, Eric S. Wang, Tinghu Zhang, Zhixiang He, Vamsidhar Velcheti, Peter S. Hammerman, Gordon J. Freeman, Richard Bonneau, William G. Kaelin, Kate D. Sutherland, Ariena Kersbergen, Andrew J. Aguirre, Guo‐Cheng Yuan, Eli Rothenberg, George Miller, Nathanael S. Gray, Kwok‐Kin Wong - Cancer Cell 2019 cited by 224

  22. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

    Authors: Sana Raoof, Iain J. Mulford, Heidie Frisco Cabanos, Varuna Nangia, Daria Timonina, Emma Labrot, Nafeeza Hafeez, Samantha Bilton, Yotam Drier, Fei Ji, Max Greenberg, August Williams, Krystina E. Kattermann, Leah J. Damon, Sosathya Sovath, Daniel P. Rakiec, Joshua M. Korn, David A. Ruddy, Cyril H. Benes, Peter S. Hammerman, Zofia Piotrowska, Lecia V. Sequist, Matthew J. Niederst, Jordi Barretina, Jeffrey A. Engelman, Aaron N. Hata - Oncogene 2019 cited by 213

  23. Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

    Authors: Juan J. Miret, Paul T. Kirschmeier, Shohei Koyama, Mingrui Zhu, Yvonne Y. Li, Yujiro Naito, Min Wu, Venkat S. Malladi, Wei Huang, William H. Walker, Sangeetha Palakurthi, Glenn Dranoff, Peter S. Hammerman, Chad V. Pecot, Kwok‐Kin Wong, Esra A. Akbay - Journal for ImmunoTherapy of Cancer 2019 cited by 155

  24. LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors

    Authors: Kelli‐Ann Monaco, Scott Delach, Jing Yuan, Yuji Mishina, Paul Fordjour, Emma Labrot, Daniel J. McKay, Ribo Guo, Stacy Higgins, Hui Qin Wang, Jinsheng Liang, Karen Bui, John Green, Peter Aspesi, Jessi Ambrose, Felipa Mapa, Lesley A. Mathews Griner, Mariela Jaskelioff, John Fuller, Kenneth Crawford, Gwynn Pardee, Stephania Widger, Peter S. Hammerman, Jeffrey A. Engelman, Darrin D. Stuart, Vesselina G. Cooke, Giordano Caponigro - Clinical Cancer Research 2020 cited by 88